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Abstract 
MONITORING NEUROMUSCULAR BLOCKADE AT THE ADDUCTOR POLLICIS 
AND ORBICULARIS OCULI WITH SPLIT DOSING OF MIVACURIUM 
CHLORIDE. 
Stephen F. Palmerton, B. S. N. 
School of Allied Health Professions -- Virginia Commonwealth 
University, 1994 
Major Director: Julie Rigoni, M.S. 
Twenty ASA class I and II patients between the ages of 
15 and 64 years undergoing surgical procedures requiring 
neuromuscular blockade and general anesthesia were selected 
at random to participate in this study. Patients taking 
medication known to interfere with neuromuscular blockade 
were excluded. All patients were given 2 mg of midazolam IV 
as a premedication. I n  the operating room, routine monitors 
were connected and baseline blood pressure, pulse and 
respirations were recorded with subsequent recordings at 5 
and 10 minutes following induction of anesthesia. 
Indirect stimulation of the ulnar nerve was achieved by 
placing ECG electrodes 2 cm and 10 cm proximal to the distal 
end of the ulnar nerve. The same type ECG electrodes were 
used at the orbicularis oculi muscle group. One electrode 
•, 
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was placed 2 cm lateral and 2 cm caudal to the outer canthus 
of the eye and the second 2 cm caudal to the first. 
Induction of anesthesia was achieved with mivacurium 
0.1 mg/kg IV followed by fentanyl 100 mcg IV and propofol 2 
mg/kg IV. The second dose of �ivacurium 0.1 mg/kg was 
administered 30 seconds after the initial dose. Baseline 
twitch response was started at both monitoring sites using 1 
Hz twitch mode with an output of 60 mA. Each patient was 
monitored until there was a loss of twitch response at 
either of the two sites. When the twitch response was 
suppressed at one site, the anesthetist performed direct 
visual laryngoscopy. If the vocal cords were open, the 
trachea was intubated. The time of twitch suppression at 
the second site was also recorded. The data collected from 
the study was examined using a paired t-test and a 
comparison of the mean times to loss of twitch at the 
orbicularis oculi and the adductor pollicis was made. All 
20 of the subjects lost the orbicularis oculi motor response 
to stimulation prior to the loss of motor response to 
stimulation at the adductor pollicis. The mean time to loss 
of twitch response was 85 seconds at the orbicularis oculi 
and 230 seconds at the adductor pollicis. 
It was concluded that there is a shorter time to loss 
of twitch response at the orbicularis oculi than at the 
adductor pollicis using 0 . 2  mg/kg mivacurium chloride in 
equally divided doses given 30 seconds apart. 
._ 
Chapter One 
Introduction 
Neuromuscular transmission blocking agents (NTBA) are 
common in today's anesthetic practice. Neuromuscular 
blockade provides skeletal muscle paralysis or relaxation. 
This paralysis or relaxation provides several advantages to 
the anesthetist and surgeon. During abdominal surgery, 
paralysis prevents coughing and movement during the closure 
of the abdominal fascia, thereby reducing the risk of bowel 
extrusion and accidental perforation. Relaxation of the 
chest wall musculature allows for easier ventilation and 
avoids the need for high ventilatory pressures, thus 
reducing the risk of barotrauma and injury to the 
bronchopulmonary tree. The use of NTBAs intra-operatively 
prevents patient movement, thus allowing delicate surgeries 
to be performed. Neuromuscular paralysis also provides 
superior exposure of the vocal cords during laryngoscopy and 
relaxes the upper airway musculature thereby preventing 
laryngospasm during instrumentation of the airway. Although 
neuromuscular blockade facilitates endotracheal intubation, 
it also increases the risk of aspiration of gastric 
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contents. Therefore, the time from onset of neuromuscular 
blockade to placement of the endotracheal tube is critical. 
Neuromuscular blockade is essential to insure successful 
outcomes for many types of surgical procedures, thus NTBA 
use is widespread in anesthesia. 
Neuromuscular transmission blocking agents interfere 
with normal conduction of nerve impulses at the 
neuromuscular junction. This action leaves the skeletal 
musculature temporarily paralyzed. The onset and length of 
the paralysis is dependent on distribution and elimination 
of the NTBA administered. Since the first clinical use of 
d-tubocurare in 194 2 by Griffith and Johnson (Calverley, 
1992), many NTBAs have been introduced. Newer NTBAs have 
been developed to minimize the time to onset and time to 
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recovery of neuromuscular blockade. The need for monitoring 
these newer, shorter acting NTBAs is essential for many of 
today's short outpatient procedures. Of equal importance is 
the need to monitor the degree of neuromuscular blockade to 
determine the optimal time for endotracheal intubation. 
Traditionally, numerous clinical signs have been monitored 
to assess the onset and recovery of neuromuscular blockade. 
At best, clinical signs are a crude measure of the onset and 
elimination of neuromuscular blockade. New monitoring 
modalities for more consistent and quantitative measurement 
of neuromuscular blockade need to be investigated. 
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In 1958, Christie and Churchill-Davidson described 
external nerve stimulation via a peripheral nerve stimulator 
(PNS) , to assess the amount of neuromuscular blockade during 
the course of an anesthetic (Viby-Mogensen, 1990) . The PNS 
gave practitioners a new and vital tool to quantitatively 
assess the onset and elimination of neuromuscular blockade. 
Peripheral nerve stimulators are used routinely today for 
assessing the optimal timing for endotracheal intubation and 
extubation. 
Three methods of peripheral nerve stimulation used 
routinely today are single twitch, train-of-four and 
tetanus. The site most commonly monitored for peripheral 
nerve stimulation is the ulnar nerve which elicits a 
response of the adductor pollicis muscle. This stimulation 
causes the adduction of the thumb towards the midline of the 
palm. The adductor pollicis twitches are easily visualized 
and quantified using the PNS. The facial nerve may also be 
monitored via the orbicularis oculi muscle group. 
Stimulation of this muscle group elicits a winking motion of 
the eye and is also easily visualized and quantified. Both 
of these sites allow the anesthetist to monitor the onset 
and decline of neuromuscular blockade for endotracheal 
intubation and extubation. 
Since the need to quantify neuromuscular blockade is 
clinically important, a comparison of different monitoring 
sites would be helpful. There are only a small number of 
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studies comparing the adductor pollicis and orbicularis 
oculi sites. For this reason, a simultaneous comparison of 
the loss of twitch response at the facial nerve and the 
ulnar nerve is made for this study. Mivacurium chloride, a 
new short acting nondepolarizing NTBA, is employed. 
Statement of the Problem 
Neuromuscular blockade of the laryngeal musculature 
allows for easier visualization and intubation of the 
trachea, but also increases the risk of accidental 
aspiration of gastric secretions. Therefore, the onset of 
neuromuscular blockade and the placement of the endotracheal 
tube need to be synchronous . This study is designed to 
compare the onset time for paralysis at the adductor 
pollicis and the orbicular1s oculi muscle groups. Both 
groups are simultaneously monitored to see if one is a 
better predictor of the onset of vocal cord paralysis. 
Hypothesis 
There is no difference between the adductor pollicis 
and orbicularis oculi muscles in time to the loss of twitch 
response and intubating conditions of the vocal cords using 
0. 2 mg/kg mivacurium chloride in two equal divided doses, 30 
seconds apart. 
Variables 
Independent. The independent variables are: 
1) mivacurium chloride and 2) time to loss of twitch. 
Dependent. The dependent variables are: 1) loss of 
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the twitch response of the adductor pollicis muscle, 2) loss 
of the twitch response of the orbicularis oculi muscle and 
3) intubating conditions of the vocal cords. 
Definition of Terms 
Adductor pollicis. The adductor pollicis is a flat 
triangular muscle responsible for the movement of the 
metacarpal of the thumb inward towards the palm. 
Intubating conditions. Intubating conditions pertain 
to the quality of visualization and position of the vocal 
cords during direct visual laryngoscopy. 
Mivacurium chloride. Mivacurium chloride is a short-
acting nondepolarizing neuromuscular transmission blocking 
agent of the bis-benzylisoquinolinium diester class. 
Orbicularis oculi. The orbicularis oculi is the 
muscular body of the ey elid composed of the palpebral, 
lacrimal and orbital muscles. Stimulation of the 
orbicularis oculi causes closure of the ey elid in a winking 
motion. 
Twitch response. Twitch response is a single muscular 
contraction due to the electrical stimulation of a nerve. 
Vocal cords. The vocal cords are two bands of elastic 
tissue stretching across the opening of the larynx with 
attachments to the thyroid cartilage and arytenoid vocal 
process. 
Assumptions 
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1. Nerve stimulators used to simultaneously observe 
the twitch responses delivered the same current to the sites 
being monitored. 
2. Placement of the leads for monitoring the 
orbicularis oculi and adductor pollicis were uniform for 
each patient. 
3. Twitches elicited from the orbiculis oculi were not 
the result of direct muscle stimulation. 
Limitations 
1. Electrodes used for the PNS may not have delivered 
the full current to the monitoring site due to poor skin 
contact or an inadequate amount of conductive gel. 
2. Deviations from normal anatomy may have caused sub­
optimal placement of the monitoring electrodes thus 
eliciting a poor muscular response. 
3. The PNS may not have delivered the set current due 
to malfunction of the device. 
Delimitations 
1. Patients selected for the study were ASA 
classification I or II, between the ages of 18 and 65 and 
between the weights of 45 to 100 kilograms (kgs) . 
2. The study was conducted at one large tertiary care 
medical facility. 
3. Two identical nerve stimulators were used and 
checked for matching output delivery by the biomedical 
engineering department of the facility. 
Conceptual Framework 
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Anatomy of the neuromuscular junction. The 
neuromuscular junction is one of the most researched and 
characterized vertebrate synapses. In man, motor efferent 
axons exit the anterior horns of the grey matter of the 
spinal cord and travel uninterrupted to the striated muscles 
of the body. Once outside the spinal cord they are known as 
the lower motoneurons (Bowman, 1980). As these motor 
efferent axons move further away from the spinal cord, 
extensive branching occurs at the nodes of Ranvier. A 
single axon, through its extensive branching, innervates 
many muscle fibers. The motoneuron and the muscle fibers it 
innervates is termed a motor unit. The number of muscle 
fibers innervated by an axon is dependent on the muscle 
fiber type. There are two types of muscle fibers in the 
8 
body, Type I (slow twitch) muscle fibers and Type II (fast 
twitch) muscle fibers. Muscles are made up of both Type I 
and Type II fibers, however the distribution of each type is 
different (Murphy, 1988) . Larger muscle groups of the body 
such as the adductor pollicis are primarily Type I muscle 
fibers. Large muscles are generally involved in slow 
movement or posture and are considered fatigue resistant. 
Small muscles of the body responsible for rapid or fine 
movement are primarily made of Type II muscle fibers. The 
orbicularis oculi and the adductor muscles of the larynx are 
examples of Type II muscle groups. (Claassen & Werner, 1992; 
Johnson, Polgar, Weightman & Appleton, 1973) . A single 
motoneuron axon's branches may innervate 5 to 15 Type II 
muscle fibers or 1, 000 Type I muscle fibers (Bowman, 1980) . 
As the motoneuron branches reach the muscle fiber, the axon 
loses its myelin sheath and further branching occurs. These 
fine terminal branches are called telodendria. These 
telodendria end with axon terminals that rest in the 
synaptic troughs on the surfaces of muscle fibers. The 
plasma membrane that surrounds the muscle fiber (sarcolemma) 
has many invaginations called synaptic folds or clefts 
(Kutchai, 1988) . The junctional gap between the telodendria 
and the sarcolemma is about 60 nanometers wide. The space 
between the telodendria and the sarcolemma is filled with a 
rich mucopolysaccharide material similar to collagen and is 
called the basement membrane. This membrane serves as a 
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filter allowing the rapid passage of acetylcholine and as a 
structural support. This basement membrane also contains 
much of the acetylcholinesterase of the junction (Bowman, 
1980). It is the area containing the telodendria axon 
terminal, the synaptic trough and the plasma membrane of the 
muscle fiber that is referred to as the neuromuscular 
junction (see Figure 1). 
Figure 1.  Diagram of neuromuscular junction. 
Note. From Pharmacology of Neuromuscular function (p. 24) 
by W. C. Bowman, 1980, Baltimore: University Park Press. 
Physiology of neuromuscular transmission. An action 
potential generated from a sensory receptor or by a 
voluntary decision made at higher brain centers travels down 
the terminal axon. Action potentials are self-propagating 
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waves of reversed membrane potential passing along a nerve 
or muscle fiber (Bowman, 1980). Action potentials 
eventually reach the lower motoneurons and telodendria 
causing depolarization of the pre-junctional membrane. This 
depolarization causes the release of the neurotransmitter 
acetylcholine into the synaptic cleft, which in turn causes 
the depolarization of the post-junctional membrane on the 
muscle cell by means of a receptor-agonist interaction. 
These events are near instantaneous, yet many events take 
place. 
Acetylcholine synthesis. Synthesis of acetylcholine 
occurs in the motoneuron and its axons. Few other cells in 
the body are capable of this synthesis. The catalytic 
enzyme of the motoneuron, choline-0-acetyltransferase, 
causes the condensation of choline and acetyl coenzyme A to 
form acetylcholine (Kutchai, 1988). Most of the cells of 
the body manufacture acetyl coenzyme A from the breakdown of 
glucose (Lehninger, 1982). Choline is abundant in plasma 
and is actively transported into the motoneuron against a 
strong electrochemical gradient. The majority of the 
choline pumped back into the cell comes from the degradation 
of acetylcholine released from the pre-junctional membrane 
(Kutchai, 1988). The acetylcholine that is ultimately 
synthesized in the motoneuron is stored in small vesicles 
within the cytoplasm. It is these vesicles of acetylcholine 
that are released into the synaptic cleft when an action 
potential arrives at the pre-junctional membrane. 
Release of acetylcholine. The action potential 
arriving at the pre-junctional axon terminal causes 
depolarization of the pre-junctional membrane. This 
membrane depolarization, in turn, causes the transient 
influx of calcium ions into the axon terminal. These 
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calcium ions cause synaptic vesicles to migrate towards and 
fuse with the plasma membrane, dumping their contents of 
acetylcholine into the synaptic cleft by exocytosis. The 
exact mechanism causing this migration of vesicles is not 
yet understood, but has been linked to calcium influx into 
the cell. The liberated acetylcholine quickly combines with 
the acetylcholine recepto�s on the post-junctional plasma 
membrane of the muscle cell causing a depolarization. The 
acetylcholine molecule 1s quickly removed from its receptor 
by the enzyme acetylchol1nesterase. This enzyme, which 
exists in high concentrations in the synaptic cleft and on 
the post-junctional membrar1e, breaks down acetylcholine by 
hydrolysis into its component parts choline and acetate. 
Choline is then actively transported back into the pre­
junctional axon and used to synthesize more acetylcholine 
(Kutchai, 1988) . 
Acetylcholine receptors. Acetylcholine receptors are 
the nicotinic type and synthesis of these receptors occurs 
within the muscle cell (Bowman, 1980). Acetylcholine 
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receptors are synthesized intracellularly from a series of 
protein subunits that are organized into protein cylinders 
and temporarily stored in the Golgi apparatus. Protein 
subunits are transported to and inserted through the cell's 
plasma membrane by an adenosine triphosphate (ATP) driven 
process. Once at the plasma membrane, the protein subunits 
are anchored into place. These protein cylinders extend 
from one side of the cell membrane to the other and become 
the acetylcholine receptors. Acetylcholine receptors extend 
into the junctional gap about 6 nanometers and are clustered 
beneath the basement membrane (Bowman, 1980) .  Acetylcholine 
receptors are made up of five subunits which are designated 
as alpha, beta, gamma and delta. Each receptor has two 
alpha subunits and one beta, gamma and delta subunit (see 
Figure 2). Each subunit is encoded by a 
�85A0� 
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Figure 2. The nicotinic acetylcholine receptor. 
Note. From "Are neuromuscular blocking agents more 
efficacious in pairs?" by P. Taylor, 1985, Anesthesiology, 
_§J_, p. 348. 
/3 
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different gene, but their overall structure is very similar. 
Subunits are composed of chains of amino acids that are 
twisted into a helix and weave in and out of the plasma 
membrane. A greater portion of the subunit's mass protrudes 
from the extracellular face of the membrane than from the 
intracellular face (Kutchai, 1988) These subunits are held 
tightly together as they extend through post-junctional 
membrane (Standaert, 1990). 
Post-junctional events. When acetylcholine is released 
from the pre-junctional membrane of the terminal axon, it 
acts as an agonist for the acetylcholine receptor binding at 
the two alpha subunits. Both alpha subunits must be 
occupied to cause a conformational change in the 
acetylcholine receptor. When this receptor-agonist coupling 
occurs, the receptor conformation changes such that a small 
channel between the exterior of the cell and the cytoplasm 
is formed. It is through this channel that selective 
cations (sodium, calcium, potassium and magnesium) enter the 
cell and cause a transient depolarization of the end plate 
region of the post-junctional membrane. This transient 
depolarization is called an end plate potential (EPP). 
These EPPs cause the "all or nothing" contraction of the 
muscle fiber by propagating the action potential around the 
post-junctional membrane (Bowman, 1980). The opening of the 
channel on the cell membrane allows the transformation of a 
neural chemical signal into an electrical event. 
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Pharmacology of neuromuscular transmission blockers. 
All neuromuscular transmission blocking agents resemble the 
molecule acetylcholine since their site of action is at the 
acetylcholine receptor on the post-junctional membrane. 
However, NTBAs differ in their mechanisms of action 
depending on the class of NTBA administered. There are two 
classes of NTBAs, depolarizing and non-depolarizing, 
currently used in anesthetic practice. 
Depolarizing neuromuscular blockers. Succinylcholine 
is the only depolarizing NTBA currently in widespread use. 
The structure of succinylcholine is that of two connected 
acetylcholine molecules (see Figure 3) . Succinylcholine 
Figure 3. Structure of succinylcholine. 
Note. From Clinical Anesthesia (2nd ed.) (p. 484). by D. R. 
Bevan and F. Donati, 1992, Philadelphia: J. B. Lippencott. 
binds at the post-junctional acetylcholine receptors. This 
agonist receptor interaction causes a conformational change 
in the receptor, opening the ion channel into the muscle 
cell and causing generation of an EPP. 
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The associated EPPs 
cause contraction of the muscle fiber in an uncontrolled 
fashion due to the lack of central nervous system 
coordination. These uncontrolled contractions are known as 
muscle fasciculations (Miller & Savarese, 1990). This is 
the same mechanism by which acetylcholine functions, however 
acetylcholine's release is under neuronal regulation and 
coordination from the cerebral cortex and cerebellar regions 
of the brain. The onset of depolarizing blockade is 30 to 
60 seconds and the succinylcholine molecule is not instantly 
broken down as is acetylcholine by acetylcholinesterase. 
This allows succinylcholine to hold the ion channel open, 
causing a continuous depolarized state. This state persists 
until succinylcholine is broken down by an enzyme in the 
blood called plasma cholinesterase. This breakdown 
generally occurs within 8 to 10 minutes following injection 
of succinylcholine. Succinylcholine causes many untoward 
side effects due to its structural similarity to 
acetylcholine and its ability to cause fasciculations. Its 
similarity to acetylcholine may cause parasympathetic 
stimulation resulting in bradycardia with nodal or 
ventricular escape rhythms, especially in children. 
Asystole has also been reported in adult patients after 
receiving a second dose of succinylcholine (Bevan & Donati, 
1992). Fasciculations cause increased intragastric 
pressure, intracranial pressure, and intraocular pressure as 
. 
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well as myalgias. There can be an exaggerated release of 
intracellular potassium into the blood. The mechanism of 
action for this release has not yet been established but may 
be attributed to the shift of potassium out of the cell when 
the ion channel is open during depolarization (Bevan & 
Donati, 1992) . 
Nondepolarizing neuromuscular blockers. The second 
class of NTBAs are non-depolarizing neuromuscular blockers. 
As their name implies, this class of drugs does not cause 
skeletal muscle depolarization. Their site of action is 
still the post-junctional membrane acetylcholine receptor 
but the interaction is one of competitive inhibition. The 
non-depolarizing drug molecule attaches to the alpha 
subunits of the acetylcholine receptor and blocks the 
attachment of acetylcholine. Therefore, no EPPs are created 
and muscle fiber contraction cannot occur. Non-depolarizing 
drugs may also act by blocking the pre-junctional sodium but 
not calcium channels (Miller, 1992). This pre-junctional 
block interferes with acetylcholine release from the pre­
junctional membrane, further inhibiting muscle fiber 
contraction. Non-depolarizing NTBAs are usually comprised 
of bulky, rigid ring systems with a quaternary nitrogen 
making them ionized and water soluble (Miller, 1992) (see 
Figure 4) . The breakdown and elimination of the 
nondepolarizing blockade is dependent on the specific NTBA. 
17 
Figure 4. Non-depolarizing NTBA mivacurium chloride. 
Note. From Clin ical Anesthesia (2nd ed.) (p. 492). by D. 
R. Bevan and F. Donati, 1992, Philadelphia: J. B. 
Lippencott. 
Pharmacology of mivacurium chloride. Mivacurium 
chloride (BW B1090U, Mivacron®, Burroughs Wellcome Co. 
Research Triangle Park, NC 27709) is a short acting NTBA of 
the isoquinolinium class. It was discovered during the 
search for a short acting non-depolarizing NTBA to replace 
succinylcholine for rapid sequence inductions and short 
surgical procedures. At the time of mivacurium's discovery, 
the shortest acting non-depolarizing NTBAs were atracurium 
besylate and vecuronium bromide. Both of these agents are 
considered intermediate acting non-depolarizing NTBAs with 
onset times to maximal blockade of 3 to 5 minutes following 
injection and durations of 20 to 40 minutes. Compared to 
succinylcholine, their onset is much slower and their 
duration is considerably longer. 
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Mivacurium chloride offers anesthesia practitioners a 
more suitable alternative to succinylcholine blockade than 
either atracurium or vecuronium for short outpatient 
procedures. The time to 100%  neuromuscular blockade is from 
2 to 3.3 minutes monitoring the adductor pollicis with 95% 
recovery in 26. 9 minutes (Savarese et al., 1988). During 
balanced anesthesia, the comparative duration of action 
following a single bolus dose to 95% recovery of mivacurium 
is approximately twice that of succinylcholine and 33-40%  
that of atracurium or vecuronium at similar dosages. Rapid 
return of neuromuscular function after mivacurium 
administration is due to its hydrolysis by plasma 
cholinesterase ( Savarese et al. , 1988). I nfusions of 
mivacurium f or up to 5 hours do not seem to have cumulative 
effects and time to recovery after discontinuation parallel 
those for patients rece1v1ng succinylcholine infusions 
(Brandom et al. , 1989). Pnase I I  block seen with prolonged 
succinylcholine infusions 1s not seen with infusions of 
mivacurium. A Phase II block resembles a non-depolarizing 
block. This change is usually the result of tachyphylaxis. 
The post-junctional mernbcane repolarizes, but does not 
respond normally to acetylcholine. The exact mechanism of 
Phase I I blockade is not known ( Stoel ting, 1991). Unlike 
succinylcholine, mivacurium does not trigger malignant 
hyperthermia. The cardiovascular response to dosages up to 
two times the effective dose (ED95) are minimal and are 
-
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similar to those of atracurium (Bevan & Donati, 1992). 
Dosages of greater than two times EDgi are associated with 
transient decreases in mean arterial pressure and increased 
incidence of histamine release. These adverse changes can 
be reduced if a dosage greater than two times ED95 is given 
in two equal divided doses, 30 seconds apart (Ali et al. , 
1993). 
Due to the significantly longer time to onset of 95% 
blockade with mivacurium, succinylcholine has remained the 
drug of choice for rapid sequence induction of anesthesia. 
However, mivacurium has gained great acceptance for use in 
short outpatient procedures. Mivacurium is routinely used 
for induction of neuromuscular blockade and is often 
preferred for continuous infusion for short procedures. 
Monitoring of neuromuscular blockade. Clinical signs 
to determine the onset of neuromuscular blockade (mandibular 
maneuverability) and amount of residual blockade (ability of 
the patient to sustain a head lift or protrude the tongue) 
are important. Ongoing assessment of physical signs of 
neuromuscular blockade undoubtedly help the anesthetist, but 
a more quantitative and reliable measurement is needed. 
This is especially true for the onset and intra-operative 
monitoring of neuromuscular blockade. During these times, 
the patient is anesthetized and can not follow verbal 
commands. It is during these times that a PNS is needed. 
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I n  1958, Christie and Churchill-Davidsen described how 
the unconscious surgical patient could be assessed for 
neuromuscular blockade using a nerve stimulator but it was 
not until the middle 1960s that the peripheral nerve 
stimulation gained popularity (Viby-Mogensen, 1990). There 
have been a number of techniques developed for monitoring 
neuromuscular blockade using the PNS. These techniques 
include single twitch, tetanus, train-of-four, and double­
burst stimulation of the peripheral nerve. 
The single twitch response is the simplest way to 
elicit a neuromuscular response (see Figure 5). 
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Figure 5. Pattern of electrical stimulation with evoked 
muscle responses to single twitch. 
Note. From Anesthesia (3rd ed.) (p. 1210) by J. Viby-
Mogensen, 1990, New York: Churchill Livingstone. 
The twitch height of the initial, pre-relaxant twitch is 
assessed. Twitch height of subsequent post-relaxant 
neuromuscular responses are then compared to the initial 
pre-relaxant twitch height. Twitches can be elicited 
continuously from 1 to 10 seconds apart (Bevan & Donati, 
1992). 
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Tetanus is the sustained delivery of current at 50 or 
100 Hertz (Hz). This causes a sustained muscular 
contraction without fade in the patient who has not received 
NTBAs. I n  the presence of non-depolarizing neuromuscular 
blockade, tetanic stimulation shows a fade in response to 
stimulation. The sensitivity of tetanic response for 
residual blockade is greater than the single twitch 
response. This sensitivity increases with frequency but if 
100 Hz is exceeded, some fade may be seen even in patients 
who have not received NTBAs (Bevan & Donati, 1992). Tetanic 
stimulation causes a phenomenon called post-tetanic 
facilitation. The large amount of acetylcholine that is 
released in response to a 50  or 100 Hz stimulation causes 
subsequent nerve stimulation to be exaggerated. This 
facilitation is self-limiting and twitch response usually 
returns to 10% of pre-tetanic values in 1 - 2 minutes 
following a 50 Hz stimulation of five seconds (Bevan & 
Donati, 1992) (see Figure 6). 
•. 
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Figure 6.  Pattern of electrical stimulation with evoked 
muscle responses to 50 Hz tetanus stimulation. 
Note. From Anesthesia (3rd ed. ) (p. 1212) by J. Viby-
Mogensen, 1990, New York: Churchill Livingstone. 
Train-of-four (TOF) stimulation was first developed in 
1968 as a means to better quantify neuromuscular blockade. 
Train-of-four stimulation employs a volley of four 
supramaximal stimuli at a frequency of 2 Hz over a period of 
2 seconds. It is a square wave pulse not exceeding 0. 2 
msec. This rapid pulse is fast enough to cause the release 
of pre-junctional acetylcholine but slow enough to avoid 
facilitation (Collins, 1993) (see Figure 7 ) .  
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Figure 7. Pattern of electrical stimulation with evoked 
muscle responses to Train-of-four stimulation. 
Note. From Anesthesia (3rd ed. ) (p. 1212) by J. Viby­
Mogensen, 1990, New York: Churchill Livingstone. 
Blockade is quantified is by a comparison of the first 
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twitch to the fourth twitch, forming a T4/Tl ratio. It has 
been clinically demonstrated that there is a correlation 
between the number of twitches suppressed and the percentage 
of neuromuscular blockade. Following the administration of 
a NTBA, the fourth twitch of the train is lost when the 
first twitch is 25% of control height, indicating a 75% 
blockade. Disappearance of the third twitch indicates a an 
80% blockade with the first twitch at 20% of control. Loss 
of the second twitch correlates with a 90% blockade and loss 
of the first twitch indicates 100% neuromuscular blockade. 
t 
t 
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The presence or absence of twitches determines the depth of 
blockade (Collins, 1993) .  
Some practitioners felt that it was difficult to assess 
the TOF response during the recovery from neuromuscular 
blockade. This led to the development of double-burst 
stimulation. This technique consists of a train of three 
impulses at 50 Hz separated by 750 msec. This ratio 
correlates closely with the train-of-four ratio but is 
easier to manually detect. At least 12-15 seconds must 
elapse between double-burst stimulations to prevent 
facilitation (Bevan & Donati, 1992) . All of these methods 
have been employed at one time or another during the 
development of neuromuscular monitoring by peripheral nerve 
stimulation. During the onset of neuromuscular blockade, 
train-of-four fade takes longer to develop than single 
twitch depression. Thus, monitoring of single twitch 
depression is preferred during the onset of neuromuscular 
blockade (Bevan & Donati, 1992). Tetanic stimulation is not 
useful on induction of anesthesia due to the inability to 
give successive stimulations less than 2 minutes apart. 
This is the result of facilitation caused by the massive 
release of acetylcholine after tetanic stimulation. 
Summary 
Once the choice of NTBA has been made for the induction 
of anesthesia and neuromuscular blockade, the anesthetist 
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must decide on the type of monitoring to be used during the 
induction and which muscle group to stimulate. Optimizing 
the timing from the paralysis of the vocal cords to the 
placement of the endotracheal tube is essential. The 
earlier the placement of the endotracheal tube after 
paralysis of the vocal cords, the less risk there is 
concerning gastric contents aspiration. Over the years, the 
discovery and use of new intermediate and short acting NTBAs 
and the employment of peripheral nerve stimulators has given 
the anesthetist more precise control over the use of 
neuromuscular blockade thus increasing safety. 
-
Chapter Two 
Review of Literature 
Little research has been completed comparing the 
orbicularis oculi to the adductor pollicis muscle for 
monitoring neuromuscular blockade. Most studies of 
neuromuscular blockade involve sole monitoring of the 
adductor pollicis, making it the standard by which all other 
methods are compared. Even in the earliest days of NTBA 
monitoring, the adductor pollicis was selected due to its 
accessibility during most surgical procedures. If the 
adductor pollicis site was not accessible, the posterior 
tibial nerve was monitored. Typically the facial nerve was 
monitored when no other site was accessible. 
Monitoring of Neuromuscular Blockade 
de Jong (1966) , in his classic study of neuromuscular 
blockade, used a "new" portable peripheral nerve stimulator 
to assess a surgical patient's relaxation during abdominal 
surgery. This study was devised to compare the strength of 
muscle contractions elicited in the small muscles of the 
hand, foot, or face from peripheral nerve stimulation with 
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the relaxation of the abdominal muscles. The study 
consisted of 65 American Society of Anesthesiologists (ASA) 
class I and II surgical patients between the ages of 20 and 
69 years. Thirty eight women and 2 7  men were studied. All 
patients were premedicated with pentobarbital and/or 
meperidine and atropine or scopolamine. Each patient 
received a sleep dose of thiopental and an intubation dose 
of succinylcholine prior to endotracheal intubation. 
Maintenance of anesthesia was achieved with 70% nitrous 
oxide, 0. 6%  to 1. 5% halothane and oxygen. Neuromuscular 
blockade was then induced with either decamethonium (n = 8), 
tubocurarine (n = 28), gallamine (n = 13) or succinylcholine 
(n = 16). Peripheral nerve stimulation was obtained using a 
battery operated PNS and needle electrodes at the ulnar 
(n = 52), posterior tibial (n = 9), and facial (n = 4) nerve 
sites. De Jong compared loss of muscle movement as measured 
by an electromyogram (EMG) to tactile and visual responses 
elicited from the PNS after administering a NTBA to 25 
subjects. This allowed de Jong to correlate the near silent 
EMG and a " flicker" of movement from the muscle group due to 
peripheral nerve stimulation. This flicker of movement was 
at the stage of optimal surgical relaxation as judged by the 
surgeon. De Jong stated that the retention of 5% to 10% of 
muscle activity shown by the EMG was synonymous with the 
flicker of the muscle group monitored via the PNS. 
-
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This study was not well controlled f or extraneous 
variables. Drug dosages, body weights, and other 
medications were not stated. The study was not controlled 
for medications that could potentiate neuromuscular 
blockade. The f acial nerve needle electrodes were placed 
such that one needle pierced the parotid gland. This 
placement could cause the needle to be insulated, thus 
altering the response of  the orbicularis oculi during 
stimulation (Wilkinson , 1988). However, time has shown that 
de Jong's original observations were correct. He concluded 
that a PNS could be substituted f or the cumbersome EMG to 
monitor relaxation at the stated peripheral nerve sites ; 
even though, the facial nerve was not monitored with the 
EMG. This was especially true at the end of  the procedure 
when the patient was extubated and transferred to the 
recovery room. De Jong f elt that this monitoring capability 
would prevent patients from being sent to the recovery room 
in a partially paralyzed condition. 
The consistent use of  train-of-four monitoring is seen 
in most studies involving neuromuscular blockade monitoring. 
Ali et al. ( 1985) compared train-of-four and single twitch 
for monitoring neuromuscular blockade during anesthetic 
induction and emergence. ASA class I and I I  patients 
between the ages of  18 and 59  years were stud ied. Each 
patient received morphine 0. 1 mg/kg intra�uscular and 
diazepam 0.15 mg/kg by mouth (p.a. ) 1 hour prior to surgery. 
·-
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Induct ion of anesthesia was achieved with 6 mcg/kg fentanyl 
and 4-8 mg/kg of thiopental. All patients were intubated 
using topical anesthesia without neuromuscular blockade. 
Maintenance of anesthesia was achieved with N2o ; o2 at a 
ratio of 4L/2L respectively. A stable neuromuscular 
response was noted for 10 minutes and then each patient was 
randomly assigned to a group receiving a bolus of either 
atracurium 0.6, 0. 1, 0. 2, 0. 4,  or 0. 5 mg/kg or vecuronium 
0. 0 2, 0. 04, 0.0 6, or 0.1 mg/kg. The time to maximal 
blockade and time to 9 5 %  recovery were recorded. Half of 
the patients were monitored with single twitch at 0. 15 Hz 
and the others with TOF responses at 2 Hz for 2 seconds 
repeated every 10 seconds. All patients were monitored 
employing the ulnar nerve at the wrist. 
The study revealed that TOF monitoring is a more 
sensitive indicator for detecting the amount of 
neuromuscular blockade present with both atracurium and 
vecuronium. However , the researchers found that in all 
instances, single twitch was superior to TOF monitoring when 
assessing the patient for time to good intubating 
conditions. This result is also stated by Bevan and Donati 
(1992). They stated that the TOF fade takes longer to 
develop than single twitch depression thus, single twitch is 
preferred for monitoring onset of blockade. This study also 
demonstrated the converse is true for monitoring recovery 
from neuromuscular blockade. Single twitch consistently 
.. 
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returned to control levels when recovery from blockade was 
not greater than 75%  for either NTBA. Thus the study 
suggested that TOF stimulation is superior to single twitch 
stimulation for monitoring return of neuromuscular f unction. 
The researchers controlled for few of the variables 
involved with neuromuscular monitoring. Weight was not 
mentioned as a criteria for the selection of patients. A 
2-value of . 05 was used for significance in this study. 
However, the researchers failed to give the number of 
patients that participated in the study. This could lead to 
significant error if the sample size was small. Placement 
of electrodes for stimulation of the ulnar nerve was not 
controlled and there was no mention of using templates for 
consistent positioning for all participants. This study 
revealed that different types of monitoring modalities can 
be utilized during different stages of neuromuscular 
blockade. 
I n  1980, Stiffel, Hameroff , Blitt and Cork used TOF 
stimulation while monitoring the facial and ulnar nerves. 
They compared use of ulnar needle electrodes to ulnar and 
facial surface electrodes. Fifteen ASA I ,  I I  and III 
patients were anesthetized with nitrous oxide, morphine and 
thiopental. Neuromuscular paralysis was induced with d-
Tubocurarine (dTC). All patients were screened for use of 
aminoglycosides, acetylcholinesterase inhibitors, ganglionic 
blockers and magnesium. Facial surface electrodes were 
�-
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placed 2 cm lateral to and 2 cm above and below the outer 
canthus of the eye. Ulnar surface electrodes were placed 2 
cm and 9 cm proximal to the distal end of the ulna. 
Standard placement was achieved using cardboard templates. 
Ulnar needle electrodes were placed subcutaneously below the 
ulnar pads. The same PNS was used throughout the study. 
Train-of-four stimulation was el icited prior to the 
administration of a NTBA. All  patients received 3 mg dTC 
and 1. 5 mg/ kg succinylchol ine for intubation of the trachea. 
After recognition of the returned TOF to pre-NTBA 
administration, dTC was given to each patient according to 
the cl inical judgement of the anesthesiologist. Ten minutes 
f ollowing the dTC inJ ection, TOF responses were el icited and 
recorded sequentially at the ulnar pads, facial pads and 
ulnar electrodes. 
Results showed a relationship between the three 
monitoring sites. The twitches from the TOF were seen as 
facial pads � ulnar needles � ulnar pads. The authors 
concluded that train-of-four responses vary considerably 
depending on the type and placement of electrodes. Ulnar 
surface electrodes give an excessive estimate of 
neuromuscular blockade, thus increasing the risk of 
inadequate muscle relaxation. I n  contrast, the facial pads 
correlated well with the ulnar needle electrodes showing an 
accurate picture of the degree of neuromuscular receptor 
occupancy by the NTBA. 
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The researchers i n  this study also failed to control 
for many extraneous variables. The weights and ages of  the 
study population were not cited. Both of these factors can 
greatly influence the results of PNS monitoring. 
Excessively obese patients can have large amounts of fat 
deposition over the monitoring site thus increasing the 
distance from the skin to the stimulated nerve. This fat 
deposition acts as an insulator that increases the impedance 
for the delivered current. This may result in the nerve 
being submaximally stimulated and give the impression of 
adequate blockade. The skin of the older patient offers the 
same problem but in terms of  decreased impedance due to 
thinness. There was no ment ion of the amount of drug used 
f or each patient on i r.uu� t 1 0 �, and all patients, received 
the same 3 mg dose of d�C . Due to the stated placement of 
the surface electrodes a t  t he facial nerve site, direct 
stimulation of the orb : c � l ar1s  oculi could have occurred. 
This would give a misrP p � ese ntation of the actual twitches 
in the presence of the N�bA . The validity of this study is 
in question since the r P s e archers were vague regarding 
controls used . 
Noninvasive monitorin g  of  the f acial nerve was tested 
by Moore and Williams ( 1 9 8 4 ) . This study was to test a 
statement made by Savarese in a 19 8 2  lecture suggesting that 
the only reliable means of assessing the facial nerve was 
using needle electrodes. Moore and Williams tested this 
-
statement by using surface electrodes at the facial nerve 
site. Fif ty patients were randomly selected from the 
surgical schedule. Each patient was to have general 
anesthesia and endotracheal tube placement. All patients 
were ASA class I ,  I I , I I I  or I V  and between the ages of 17 
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and 81 years. Patients were selected without regard to sex 
or race. A single Professional I nstruments Company, model 
NS-3a™ peripheral nerve stimulator was used with silver 
chloride pediatric ECG monitoring electrodes. The first 
electrode was placed anterior to the ear lobe, and the 
second was placed posterior and inf erior to the same ear 
lobe. Tetanus, twitch and TOF stimulation were used to 
assess neuromuscular blockade. The study revealed that 94% 
of the patients had observable twitches at the orbicularis 
oris, orbicularis oculi or zygornaticus maj or muscles. The 
researchers f ailed to state the type of stimulation the 
patients received and the outcome of each type. There was 
also a lack of  information on 6%  of patients that did not 
have observable twitches. However, this research 
demonstrates a high degree of success for stimulating the 
facial nerve without the use of needle electrodes. 
Corn arison of Various Muscle Grouo R��nses tQ 
Neuromuscular Stimulation 
Caff rey, Warren and Becker (1986) were one of the f irst 
groups that directly compared f acial nerve stimulation to 
p 
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ulnar nerve stimulation during neuromuscular blockade. The 
study consisted of nine ASA I or II patients between the 
ages of 26 and 7 8  years. Patients that were markedly obese 
or had underlying neuromuscular disease were excluded from 
the study. All patients received 25 mg meperidine , 2. 5 mg 
diazepam and 0.2 mg atropine as a premedication. I nduc tion 
of anesthesia was achieved with 5 mg/kg thiopental and 1 . 5 
mg/kg suc cinylcholine. I ntubation of the trachea was 
achieved and thumb twitch height was allowed to return to 
pre-relaxant levels. Anesthesia was maintained with 
enflurane 2. 0 - 2. 5% and 50 % N2o ; o2. Atracurium was 
titrated to loss of a single twitch and loss of tetanic 
response to stimulation at the facial and ulnar sites. 
Patients were then allowed to recover from the NTBA while 
being monitored with the TOF techn ique. Orbicularis oculi 
and adductor pollicis responses to stimulation were assessed 
with linear force transducers. 
The study showed that the first and fourth twitch at 
the facial nerve site consistently returned to pre-NTBA 
levels before the ulnar nerve site. However , when the TOF 
returned to normal levels at the facial nerve site, 
considerable weakness was still apparent as tested by the 
sustained head lift technique. Train-or-four response at 
the ulnar nerve site at the same time showed significant 
f ade. Caffrey et al. (1986) concluded that the facial nerve 
response returns prior to the ulnar nerve response and there 
was less chance of residual neuromuscular blockade if the 
ulnar site was assessed for reversal of NTBA blockade. 
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This study controlled many of the variables associated 
with neuromuscular blockade monitoring. The number of 
patients studied was small, but results were consistent and 
signif icance was evaluated at a 2 < . 05. P lacement of 
electrode patches was generalized , therefore the risk of 
direct muscle stimulation at the orbicularis oculi was 
increased. This study did not compare ulnar and facial 
nerve stimulation on induction of neuromuscular blockade. 
However, the results showed that the facial nerve was a more 
sensitive indicator f or assessing the return f rom 
neuromuscular blockade during the intra-operative period. 
The authors suggested that the anesthet ist should use 
caution when monitoring the facial nerve response to 
stimulation f or extubation criteria. 
Campbell (1 989) compared the facial and ulnar nerve 
response during vecuronium neuromuscular blockade. The 
times to onset and recovery of response to blockade were 
recorded in 13 ASA I and I I  patients. All patients were 
between 18 and 54  years of age and were not obese. All 
patients were free f rom neuromuscular disease and presented 
for surgery in sites other than the face or upper 
extremit ies. These patients were divided into one of two 
groups as f ollows: Group 1 was given a dose of 0.1 mg/kg 
vecuronium and Group 2 was given 0.5 mg/kg vecuronium to 
•. 
induce muscle relaxation after induction of anesthesia. 
Induction of  anesthesia was achieved with thiopental 3-5 
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mg/kg and f entanyl 2 mcg/kg. Anesthesia was maintained with 
0. 5 - 1.5 % isoflurane and 5 0 %  nitrous oxide. The two groups 
were stimulated with the TOF modality every 2 minutes 
f ollowing intubation and every 2 minutes until recovery of 
one muscle group was demonstrated. At that point, the sites 
were monitored more f requently until the TOF was ev ident in 
both muscle groups. Placement of electrodes at the facial 
and ulnar sites were consistent  using a cardboard template 
and as indicated by Stif f el et al. (1980) .  Baseline TOF 
twitch responses were recorded prior to neuromuscular 
blockade and each patient served as their own control. Both 
muscle groups were stimulated and monitored simultaneously. 
Simultaneous stimulation was achieved by using a single 
nerve stimulator equipped with two sets of electrode leads. 
Results obtained f rom Group 1 revealed that after 2 
minutes, all hand responses evidenced 100 % blockade while 
the f ace showed four responses to stimulation. I n  Group 2 ,  
neuromuscular blockade took longer to develop due to the 
smaller dose of vecuronium. At 4 minutes, the hand showed 
100% blockade and the face showed two to four responses to 
stimulation. The TOF recovery from vecuronium blockade was 
significantly earlier at the face than at the hand. 
The researcher concluded that the facial neuromuscular 
response was more resistant to and recovered earlier from 
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vecuronium blockade than the ulnar neuromuscular response. 
The explanation offered was a difference in the contribution 
of Type I and Type II muscle fibers that make up the 
orbicularis oculi and the adductor pollicis groups. The 
statement was also made that the extraocular and facial 
muscles have a proportionately larger number of 
neuromuscular junctions as compared to other muscles of the 
body and are more difficult to ablate with NTBAs. 
Unfortunately, there was no mention of control for the 
amount of current delivered to each of the two monitored 
nerves. A single nerve stimulator delivers a constant 
current over a specified range of impedances. However, the 
stimulator used by the researcher had two sets of leads. 
This would cause the delivered current to be split between 
the two parallel circuits created when attaching the two 
sets of positive and negative electrodes. There is 
considerable difference in the impedance at the facial nerve 
where the two poles are 3 centimeters (cm) apart and the 
ulnar nerve where the poles are 7 cm apart. A 
proportionately higher amount of  the current delivered by 
the PNS follows the path of least resistance which is at the 
facial nerve electrodes. This results in the f acial nerve 
being supramaximally stimulated and the ulnar nerve being 
submaximally stimulated. This difference in the amount of 
current delivered for stimulation could account for the loss 
of response at the ulnar site prior to the facial site. 
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Donati, Meistelman and Plaud (1990) studied the 
relationship between the diaphragm, orbicularis oculi and 
the adductor pollicis muscles with vecuronium neuromuscular 
blockade. Sixteen adult patients scheduled for laryngeal 
and pharyngeal endoscopy were selected. Patients with 
respiratory, cardiovascular and neuromuscular disease were 
excluded from the study as were patients with excessive 
alcohol intake and current administration of medications 
affecting neuromuscular function. 
The first group received 0. 0 7  mg/ kg vecuronium and the 
second group received 0. 04 mg/ kg vecuronium for muscular 
paralysis. Preoperative diazepam 5 - 10 mg was given to all 
participants 1 hour prior to scheduled surgery. Anesthesia 
was induced with intravenous alfentanil 20 - 30 mcg/ kg and 
propofol 2-3 mg/ kg. Endotracheal intubation was achieved 
without the use of NTBAs. Anesthesia was maintained with a 
propofol infusion at 10 mg/ kg / hr with intermittent doses of 
alfentanil. Surface electrodes were applied to the ulnar 
nerve at the wrist, to the right phrenic nerve at the base 
of the neck and the temporal branch of the right facial 
nerve, anterior to the ear lobe. The response to the PNS 
was measured at the adductor pollicis with a force 
transducer. The responses from the orbicularis oculi and 
the diaphragm were measured via an electromyograph. 
Supramaximal stimulation was achieved at all three monitored 
sites prior to the administration of vecuronium. 
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Supramaximal TOF stimulation was delivered every 10 seconds 
to all three sites and baseline responses were recorded for 
2 - 3 minutes. Vecuronium was then given at 0. 4 mg/ kg for 
eight patients and 0. 7 mg/ kg for the other eight patients. 
Times to 5%, 50% and maximum T1 blockade were made as well 
as 25% and 75% T1 recovery. The T 1 response of the 
orbicularis oculi and the adductor pollicis were plotted 
against the T1 response of the d iaphragm for onset and 
recovery from vecuronium blockade. 
I n  both groups, onset and recovery from NTBA blockade 
was more rapid in the diaphragm than at either the adductor 
pollicis or the orbicu lar1s oculi muscles. When comparing 
the adductor pollicis to  the orbicularis oculi, the 
neuromuscular blockade at t he orbicularis oculi was only 
slightly slower than t�e d ; aphragm whereas, the adductor 
pollicis blockade took s 1 g � 1 f icantly longer to develop. 
Maximal blockade occur, ed 1 n  the diaphragm at 2.9 minutes, 
at the orbicularis ocu l 1  a t  3 . 8 minutes and at the adductor 
pollicis at 6.8 minutes w i t h  a vecuronium dose of 0.04 
mg/ kg. The vecuron 1um dose of 0.0 7 mg/ kg showed almost 
identical results. R e cov ery f rom neuromuscular blockade was 
fastest at the diaphragm , followed by the orbicularis oculi 
and the adductor pollic 1 s . Donati et al. (19 90) stated that 
the amount of NTBA required to cause a 90%  blockade at the 
diaphragm is 40 to 100%  greater than that required for 
blockade at the adductor pollicis. However, diaphragmatic 
. 
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paralysis occurs and resolves sooner due to dif ferences in 
blood f low and early distribution of the relaxant. The 
researchers stated that the stimulation of the phrenic nerve 
during surgery is impractical and that the orbicularis oculi 
should be used since it most accurately reflects the amount 
of  paralysis at the diaphragm. The researchers controlled 
f or many variables of  neuromuscular blockade monitoring and 
the drug dosages were controlled on a milligram or microgram 
per kilogram basis. The number of subjects was small but 
the results were consistent (Q = . 01)  
Donati, Meistelman and Plaud (1991) continued their 
research of  neuromuscular blockade when they compared 
vecuronium neuromuscular blockade at the adductor pollicis 
and the adductor muscles of  the larynx. Twenty ASA I or I I  
adult f emales were selected for the study. Patients with 
abnormal airway exams, cardiovascular, respiratory, hepatic 
and renal disease, previous head and neck surgery or 
chemotherapy known to interfere with neuromuscular function 
or blockade were excluded f rom the study. Upon arrival to 
the operating room, baseline ECG, pulse oximetry, and 
arterial blood pressure were monitored. I nduction of 
anesthesia was achieved with propofol 2 - 4  mg/kg, and 
f entanyl 2-5 ug/kg. An endotracheal tube was placed with 
direct visual laryngoscopy placing the cuf f  between the 
vocal cords without use of  an NTBA. End tidal carbon 
dioxide (ETC02) was held constant between 3 5-40 mmHg and 
anesthesia was maintained with propofol and fentanyl. 
Nitrous oxide and halogenated agents were avoided. The 
adductor pollicis was stimulated by placing skin type ECG 
electrodes at the ulnar nerve site at the wrist. 
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Stimulation of the recurrent laryngeal nerve was achieved by 
placing the negative electrode on the skin overlying the 
notch of the thyroid cartilage, with the positive electrode 
on the sternum or the forehead. Adductor pollicis movement 
was recorded using a force transducer. The vocal cord 
response was monitored by fluctuations in the endotracheal 
tube cuff pressure and recorded with a chart recorder. 
Neuromuscular blockade was induced using 0. 4 mg / kg in 10  of  
the patients and 0. 7 mg/ kg in the remaining 10  patients. 
Supramaximal TOF stimulations were applied to both sites to 
obtain a baseline response. Induction of blockade was 
measured using TOF pulses at 10 second intervals. Onset 
time was defined as the interval between the time of 
injection to maximal T, blockade. 
Maximal blockade was less intense at the vocal cords 
than at the adductor pollicis at both dosages. In all 20 
participants, onset was f aster and recovery was earlier at 
the vocal cords than at the adductor pollicis. The 
researchers concluded that there are important differences 
in the laryngeal muscles and the adductor pollicis with 
regards to their response to vecuronium. They also stated 
that a possible explanation for the differences in 
42 
reslstance and speed of onset was due to differences in 
muscle fiber tissue types. They clted that experlmental 
data revealed that fast twitch muscles were more resistant 
to neuromuscular blockade. The laryngeal muscles were made 
of fast contracting fibers unlike those of the slow 
contracting adductor pollicis muscles. The suggestlon was 
also made that the faster onset of the blockade at the vocal 
cords, as in the diaphragm, was due to blood flow. 
Therefore, assessment for optimal time to intubation should 
be governed by a fast twitch muscle like the orbicularis 
OCUll. 
The researchers controlled for many varlables but only 
female subJects were studied. There was also a lack of 
control for lead placement at the ulnar nerve, thus dlrect 
muscle stimulation could have occurred. The results were 
consistent at a 2 value � .05, thus adding validity to the 
study. 
The method of neuromuscular blockade monitorlng can be 
as varied as the site chosen for stimulation. Little 
research has been focused on considering both the method and 
the site for assessing optimal intubating conditions of the 
vocal cords. Donati et al. (1990) demonstrated that the 
onset of neuromuscular blockade at the diaphragm and 
orbicularis oculi muscle precede that of the adductor 
pollicis. Donati et al. (1991) demonstrated the onset of 
neuromuscular blockade at the laryngeal muscles correlated 
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well with the onset times for the diaphragm and orbicularis 
oculi ( see Figure 8) . 
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Note. From Clinical Anesth_esi.f! ( 2nd ed. ) ( p. 499) . by D. R. 
Bevan and F. Donati, 1992 , Philadelphia : J. B. Lippencott. 
Therefore, monitoring the orbicular1s oculi muscle using 
single twitch stimulation should provide the anesthetist 
with the earliest signs of optimal intubating conditions. 
Iwasaki, Igarashi , Omote and Namiki ( 1994) studied the 
sensitivity of the cricothyroid (CT) and posterior 
cricoarytenoid ( PCA) muscles to vecuronium induced 
neuromuscular blockade. Nine ASA I and I I  patients 
undergoing surgery for total laryngectomy for unilateral 
laryngeal cancer were selected to participate in the study. 
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All patients received atropine 0. 5 mg IV and midazolam 2. 5 
mg intramuscularly 1 hour prior to induction of anesthesia. 
A sleep dose of thiamylal, 4 - 5 mg/kg and fentanyl 3 - 5 
mcg/kg was given. Succinylcholine 1 mg/kg was given to aid 
endotracheal intubation. Anesthesia was maintained using 
additional fentanyl, midazolam and 66% N2o with 34% o2. The 
Halogenated agents were avoided to prevent potentiation of 
the neuromuscular blockade. 
Surgical exposure facilitated the placement of 
stainless steel electrode leads into the superior laryngeal 
and recurrent nerves on the unaffected side. This placement 
provided indirect stimulation of the CT and PCA muscles. 
Stimulation was achieved using pulses of 0. 2 millisecond 
duration every 10 seconds at 1. 4 to 1 2  mA. Twitch height 
following stimulation was measured using an EMG for the 
muscles of the larynx and a mechanomylogram at the adductor 
pollicis for 5 minutes . Once stable baseline recordings 
were established, vecuronium was continuously infused at a 
rate of 0.01 mg/kg/min f or 10 minutes. Recordings of the 
twitch height depression were made and compared. 
The results of the study revealed that the intrinsic 
laryngeal muscles did not behave similarly with vecuronium 
induced neuromuscular blockade. I n  all cases, the CT and 
adductor pollicis muscles were clearly more sensitive to 
vecuronium neuromuscular blockade than the PCA muscle. The 
recovery from neuromuscular blockade was not monitored. 
The researchers did not control f or many of the 
variables affecting neuromuscular blockade such as weight 
and pre-existing neuromuscular disease which could lead to 
erroneous results. The small number of patients in the 
study could also have lead to false conclusions. However, 
100% of the patients had the same results which helps to 
lend some validity to this study. 
Mivacurium Chloride 
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Savarese et al. (1 988) investigated the neuromuscular 
blocking properties of mivacurium chloride to include 
potency, dose-response relationships for onset and duration 
and reversibility with neostigmine. Seventy-two ASA 
physical status I and II patients, between the ages of 18  
and 49  years, were studied. Patients with preexisting 
neuromuscular, cardiovascular, renal or hepatic disorders 
were excluded. All patients received intramuscular morphine 
(0. 1-0. 15 mg/kg) and/or diazepam (0.1-0.2 mg by mouth) 1 
hour preoperatively. All patients had radial arterial 
cannulae placed for blood pressure monitoring. Anesthesia 
was induced using thiopental (4-8 mg/kg) and fentanyl (4-8 
mcg/kg) I V. Nitrous oxide and oxygen ( 4 L/ 2L inspired 
mixture) were delivered via face mask. Intubation of the 
trachea was achieved without muscle relaxant by using 
topical lidocaine. Blood pressure and heart rate were 
measured at 1 minute intervals for 5 minutes bef ore and 10 
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minutes following the injection of mivacurium. The single 
twitch of the thumb was evoked at 0. 1 5  Hz using square wave 
pulses 0.2 msec in duration at the ulnar nerve with needle 
electrodes. Train-of-four stimulation (2 Hz for 2 sec) was 
applied at 5- 10 minute intervals during maintenance and 
recovery from neuromuscular blockade. Adduction of  the 
thumb was quantified with a force-displacement transducer. 
The results of the study showed that 0. 1, 0. 15,  0. 2, 0. 25  
and 0. 3 mg/kg of mivacurium given as a single dose resulted 
in a mean time to 95%  twitch recovery of 25. 3, 25. 1 ,  27. 9 ,  
3 0. 1 and 29.9 minutes and a mean time to T4 > 70%  of 28. 7,  
28. 9, 30.8, 3 2. 2  and 3 1. 6  minutes respectively. Savarese et 
al. ( 1988) also showed that the molar potency ratio of 
mivacurium was similar to vecuronium and pancuronium and 
almost three times t h a t  v i  at racurium. However , multiple 
doses of up to three t i me s �ivacurium ' s  Eo9 5  only prolonged 
the neuromuscular blocka d e  : ,y 5 to 10 minutes. This 
disproportionate incr e a f e  : �  dose to a small extension of 
duration of effect is u n l : ke any other non-depolarizing 
neuromuscular blocker . 
The hydrolysis o f  � 1 va=urium by plasma cholinesterase 
was also studied with regard to the effects of reversal with 
the anticholinesterase neostigmine. At the conclusion of 
the study, eight patients were reversed with neostigmine. 
Savarese et al. (1988) found that reversal of the 
neuromuscular blockade did not potentiate the neuromuscular 
-
blockade from mivacurium. However , the induced recovery 
only preceded the spontaneous recovery by 4 minutes. 
The study by Savarese et al. (1988 ) was one of the 
first conducted measuring the pharmacodynamics of 
mivacurium. The study was well controlled for medical 
conditions that could potentiate neuromuscular blockade. 
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The large sample size could provide statistical significance 
however, there was no mention of confidence intervals or 
levels of significance throughout the article. Ulnar needle 
electrodes reduced skin impedance to electrical nerve 
stimulation, but exact placement of the electrodes was not 
specified other than at the wrist. 
Savarese et al. ( 1989 ) continued their studies of 
mivacurium chloride. This study f ocused on the 
cardiovascular effects of mivacurium and looked specifically 
at heart rate, blood pressure and histamine release at 
various dosages of mivacurium. Ninety-seven ASA physical 
status I and II patients o f  bot h  sexes between the ages of 
18  and 49  years with weights rang ing from 50 to 100 kg were 
studied. Patients with preexisting neuromuscular, 
cardiovascular, renal or hepatic disorders were excluded . 
All patients were given intramuscular morphine (0 . 1-0 . 15 
mg/kg) and diazepam by mouth ( 0.1-0.2 mg/kg ) .  All patients 
had a 20 gauge arterial catheter placed to monitor blood 
pressure. Induction of anesthesia was achieved using 
thiopental ( 4-8 mg/kg) and fentanyl (4-8 mcg/kg) I V. 
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Nitrous oxide and oxygen ( 4 L/2L inspired mixture ) was 
delivered via face mask. Intubation of the trachea was 
achieved without muscle relaxant by using topical lidocaine. 
After obtaining a stable baseline of heart rate and blood 
pressure for 10 minutes mivacurium was injected over 10 to 
15  seconds. During injection of mivacurium at ED9 5  and 
above , direct arterial pressure and heart rate were 
continuously recorded. Twitches were evoked by stimulation 
of the adductor pollicis at 0. 15 Hz and were continuously 
recorded. Cardiovascular responses were recorded f or 10 
minutes after injection or until blood pressure and heart 
rate returned to 95% of control levels. Mivacurium dosages 
given ranged from 0.03 to 0. 3 mg/kg. Three additional 
groups of nine patients were given the same dosages as above 
but over a longer 30 to 60 second injection time. Plasma 
histamine levels were assayed after all doses greater than 
ED9 5. Arterial blood samples were drawn immediately before , 
and at 5 minute and 10 minute intervals following the 
mivacurium injection . The incidence of decline of mean 
arterial pressure less than ( < ) 80% of control did not occur 
in the groups receiving 0.1 or 0.15 mg/kg of mivacurium 
given as a bolus over 10 to 15  seconds. However , the group 
receiving 0. 15  mg/kg mivacurium had a 33% incidence cf 
increased serum histamine release greater than ( >) 1 , 000 
picograms/ml of blood. Dosages greater than 0.15 mg/kg 
mivacurium also resulted in equivalent histamine release and 
• 
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decline of mean arterial pressures > 80% of control values. 
The only exception was the group given 0. 25 mg/ kg injected 
over a 60 second time period where the results were similar 
to the 0.1 mg/kg dosage group . 
This study demonstrated that mivacurium's effects on 
the cardiovascular system were signif icant at dosages 
greater than 2 X ED9 5  when given over 10-15 seconds. The 
authors attributed the cardiovascular effects to the 
histamine release as shown earlier. However, Savarese et 
al. (1989) also found that a second administration of 
mivacurium over 10-15 seconds only decreased the blood 
pressure and heart rate to 98 and 92% of control values. 
The large number of participants in this study and the 
controls f or neuromuscular disease added conf idence in the 
exhibited results. Savarese et al. (1989) also used a 2-
value of .05 to indicate significance. A lack of 
description of lead placement for neuromuscular blockade was 
not detrimental to the study results in that the focus was 
on specific dosages of mivacurium and responses of the 
cardiovascular system, not the amount ot  neuromuscular 
blockade. 
Brandom et al. (1989) dev ised a study to compare 
mivacurium and succinylcholine administered by bolus and 
infusion. Thirty ASA I and II patients between the ages of 
18 and 57 years were studied. Women of child bearing age 
were excluded as well as patients receiving aminoglycoside 
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antibiotics or antihistamine drugs. All patients received 
diazepam 0.1-0.2 mg/kg by mouth and or intramuscular 
morphine 0.05-0.1 mg/kg 1 hour prior to induction. Blood 
samples were drawn to measure plasma cholinesterase activity 
and dibucaine number. I nduction of anesthesia was achieved 
with thiopental 3-5 mg/kg and fentanyl 1-6 mcg/kg and 
maintained with 70%  nitrous oxide and 30% oxygen. The ulnar 
nerve was stimulated with repeated TOF via surface 
electrodes at the wrist. Measurements of supramaximal and 
continuous twitch response were obtained using an EMG of the 
adductor pollicis. 
The percent of neuromuscular blockade was calculated 
from the amplitude of the first TOF responses (Tl) after 
bolus administration to the Tl before drug administration. 
After the infusion was stopped, recovery was determined from 
the first stable Tl response to a TOF ratio (T4-Tl) that was 
greater than 0.9. Tracheal intubation was attempted 60 
seconds after succinylcholine and 90 seconds after 
mivacurium administration. Intubation was attempted at the 
specified time interval if 80% neuromuscular blockade had 
been achieved. I f  neuromuscular blockade was not greater 
than 80% at the time interval specif ied, intubation was 
postponed until 80% blockade was achieved. conditions of 
intubation were graded as excellent ( no resistance to 
laryngoscopy, no movement of vocal cords) ; good (same as 
excellent but some coughing) ; fair (no resistance to 
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laryngoscopy but movement of the cords and coughing ) ;  poor 
(intubation could not be performed). Infusions of 
succinylcholine and mivacurium were started with the return 
of one twitch response of the TOF. Infusions were stopped 
at the end of the procedure and patients were monitored for 
recovery of neuromuscular function. The times between 
cessation of infusion and recovery to 5% (T5 ) ,  25%  (T25), 
50% (T50), 75% (T75), and 95% (T95) of baseline were noted. 
All patients developed complete neuromuscular blockade 
from the bolus dose of succinylcholine 1 mg/kg. Twelve of 
the 14 patients receiving mivacurium 0. 25 mg/kg exhibited 
complete neuromuscular blockade. The two patients not 
obtaining complete neuromuscular blockade were excluded from 
the study. 
The study revealed that the onset of neuromuscular 
blockade was significantly shorter for succinylcholine than 
that for mivacurium. Most patients receiving the 0. 25  mg/kg 
bolus of mivacurium did develop facial and truncal flushing. 
The recovery indices (T25-T7 5) after infusions of 
succinylcholine and mivacurium were approximately 6 minutes. 
The recovery index for mivacurium after a bolus dose was 
also about 6 minutes. 
The controls f or this study were poorly executed. Lack 
of a specific placement of electrodes for eliciting 
neuromuscular response can lead to many erroneous results. 
There was no mention of a control for patient weight which 
can also lead to error due to altered conduction of 
peripheral nerve stimulation. It was impossible to 
ascertain why two patients failed to obtain complete 
neuromuscular blockade. The number of patients was 
sufficient for providing conf idence in the results with a 
stated £ <  .0 5. 
Mivacurium chloride has been shown to  have a 
predictable and consistent hemodynamic and pharmacologic 
prof ile. When mivacurium is administered at 2 X ED9 5, it 
has an onset time between 90 and 180 seconds which is 
comparable to the widely used NTBAs atracurium and 
vecuronium. Mivacurium ' s  advantage is seen in its rapid 
hydrolysis and elimination which is almost half the time 
required for vecuronium or atracurium. This makes 
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mivacurium preferable for short and intermediate length 
surgical procedures. Reversal of mivacurium's neuromuscular 
blockade may not be necessary thus making it ideal for 
outpatient procedures where the incidence of nausea and 
vomiting may increase if a anticholinergic is used for 
reversal. Unfortunately, mivacurium's onset time for 
neuromuscular blockade is inf erior to that of 
succinylcholine thus precluding its use for rapid sequence 
intubation. 
Chapter Three 
Methodology 
Research Design 
The design for this study was quasi-experimental. An 
experimental design was not feasible and a control group was 
not used since each person served as his/her own individual 
control. This study compared the relationship between the 
facial and u lnar nerve-mediated response to neuromuscular 
blockade with mivacurium chloride during intubation. 
Patients were chosen as t hey presented for surgery and met 
the population inclus ion cri teria for the study. 
population and Samp l e  
Twenty ASA class I and I I  male and female adults 
between the ages of 1 8 - b �  years, with body weights between 
45-100 kg requiring genera l anesthesia with neuromuscular 
blockade were selectea f o" study. Those patients with known 
peripheral neuropath i es associated with diabetes , myasthenia 
gravis, myotonia and muscu lar dystrophy were excluded from 
the study along with patients receiving any medication that 
potentiates NTBA blockade. 
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Set ting 
This study was conducted at a large tertiary care 
medical facility. The data was collected over a period of 8 
weeks. 
Data Collection Procedure 
All patients participating in the study were given 
premedication of 2 mg of midazolam I V. Upon arrival to the 
operating room, routine monitors were connected and baseline 
blood pressure, pulse and respirations were recorded with 
subsequent recordings at 5 and 10 minutes f ollowing 
induction of anesthesia. 
I ndirect stimulation of the ul nar nerve was achieved by 
placing commercially available silver chloride ECG 
electrodes 2 cm and 10 cm proximal to the distal end of the 
ulnar nerve. Placement of the electrodes at these sites 
should have avoided any direct muscle stimulation of the 
adductor pollicis and elicited an indirect stimulation via 
the deep branch of the ul nar nerve ( Wilkinson, 198 8). The 
same type of ECG electrodes were used to monitor the 
orbicularis oculi muscle group. The first electrode was 
placed 2 cm lateral and 2 cm caudal to the outer canthus of 
the eye and the second 2 cm caudal to the first. This 
placement avoided direct stimulation of the orbicularis 
oculi and maximized stimulation indirectly via the facial 
nerve. Each site selected for lead placement was cleaned 
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with  a l c ohol ple d g e t s  pr i or t o  pl acement t o  r emove any 
e x c e s s  oi l s  which c ou l d  cause  i n c r e a s ed impedance.  The 
le ads we r e  placed  on t he s ame s ide  of t he body f or 
mon i t or ing t h e  orb i c u l ar i s  ocu l i  and t he adductor pol l i c i s .  
I nduc t i on o f  ane s t h e s i a  was achieved w i t h  0 . 1  mg / kg I V  
of mivacur ium f ol l owed b y  1 0 0  mc g o f  f entanyl I V  and 2 mg / kg 
I V  of pr opof ol . The s e c ond dos e  of mivacu r i um 0 . 1  mg / kg was 
admin i s t e r e d  30 s e c onds a f t e r  t he i n i t i a l  dos e .  Bas e l ine 
twi t c h  r e s pons e  was i mme d i a t e l y  s t a r t e d  at both  mon i t or ing 
s i t e s  us ing  1 Hz  twitch  pe r s e c ond mode  with  an output of 60 
mA . Each  pat i ent was s imul t aneou s l y  mon i t or e d  unt i l  there  
was  a l os s  of  twitch  r e spons e  at e i ther  of  the two  s i t e s . 
When t he twi t c h  r e sponse  had been  suppr e ss e d  at  one s i t e , 
the ane s t he t i s t  pe r f ormed d i r e c t  v i sual  l a ryngoscopy . I f  
the voc a l  c ords  we r e  r e l axed  and ope n , t he t r achea  was 
intubat e d .  I f  t he voc a l  c ords  we r e  not r e l axed , t h e  
ane s t h e t i s t  withd r ew the laryngos c ope a n d  wai t e d  f or the 
suppr e s s i on of t he s e c ond mon i t or i ng s i t e .  A f t e r  succe s s f u l  
t r ache a l  i ntuba t i on , the ane s t he t i s t  charted  t he t ime the 
s e c ond 0 . 1  mg / kg dos e  of  mivacur ium was given , t he t ime the 
f i r s t  twi t c h  was suppr e s sed  and at whi c h  mon i t or ing s i t e , 
whe ther  t he voc a l  c ords  were  open or c l os e d , i f  t he t r achea 
was intubat e d , and the t ime the s e c ond mon i t or ing s i t e  
twitch  suppr e s s i on was achieved.  I f  t he t r achea was  not 
intubated w i t h  the los s  of the twi t c h  r e sponse at t he f i r s t  
mon i t or ing s i t e , the t ime and r e laxat i on o f  t he voc a l  cords  
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would be recorded with the laryngoscopy following the loss 
of the twitch response at the second monitoring site. The 
anesthetist also recorded the side of the body used for 
peripheral nerve stimulation and if there was evidence of 
histamine response monitored by facial or truncal flushing. 
I nstrumentation 
The Fischer and Paykel N S 2 5 2  peripheral nerve 
stimulator is a f ully programmable solid state battery 
powered instrument designed f or monitoring peripheral 
neuromuscular blockade. It utilizes three 1.5 volt AAA 
batteries to deliver the power to the pulse generator. The 
pulse generator disburses a square wave pulse 200 
microseconds (+/- 5 microseconds) in duration with an 0utput 
rise/f all time of less than 5 microseconds using th s single 
twitch mode at 1 Hz. The maximum load impedance f or single 
twitch is 4 kilo-ohms at 80 mil l iamperes (mA) and the 
ability to generate a mr-ximum output of 35 0 volts. The 
manufacture� specifications are maintained for a minimum of 
30 0 hours of use with newly charged alkaline batteries. I f  
battery failure should occur, audio alarm and liquid crystal 
display \ LCD) are activated to info�m the user. I n  
addition, the LCD continuously displays the current to be 
delivered in mA. I f  the set current is not delivered due to 
a disconnected lead, excessive impedance, or dry electrode 
patches, a fault symbol and audio alarm are initiated. The 
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ability to ad just and set the output current is achieved by 
pressing membrane touch switches . There are 14 switches in 
all used for setting functions as well as turning the 
stimulator on and off. The output current used for this 
study was preset at 60 rnA delivered by a single twitch at 1 
Hz which is suf ficient to cause supramaximal twitch 
response. 
Statistical Analysis 
Data collected from the study was examined using a 
paired t-test and a comparison of the mean times to loss of 
twitch at the orbicularis oculi and the adduc tor pollicis 
was made. The paired t-test was selected due to the 
measurement of  two variables in the same individual with 
each subject acting as his own control. The mean change in 
heart rate at 5 and 10 minutes after injection of 
mivacurium , the mean change in blood pressure at 5 and 10 
minutes after injection of mivacurium, age, weight, sex and 
ASA classif ication were compared to the loss of twitch at 
the orbicularis oculi and the adductor pollicis using 
regression analysis and scatter plots to ascertain any 
signif icance in the relationship among these variables. The 
level of  significance was set at a £ < .01. 
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Inf ormed Consent 
A waiver of informed consent was obtained from the 
University institutional review board. The waiver was 
granted due to the use of medications, dosages and 
monitoring techniques that fall within the standard of care 
for anesthetic practice. 
Chapter Four 
Results 
Sample Population 
The 20 patients stud ied had a mean age of 3 6  years w ith 
the youngest bei ng 1 5  years and the oldest 64 years. This 
sample population was made up of f ive females (20%) and 1 5  
males (80%). The mean weight of the sample was 76.6 kg 
rangi ng f rom 4 5  kg to 100 kg. Neuromuscular stimulation 
response was obtained on the left side of the body in 5 
( 20%) subjects and on the right side of the body i n  1 5  (80%) 
of the subjects. The orbicularis oculi and adductor 
pollicis were monitored exclusively on one side in each 
sub j ect. All patients were also mon itored for histamine 
response as demonstrated by facial or truncal f lushing and 
for movement during laryngoscopy. 
Comparison of the Loss of Twitch ReSQQil�� 
All 20 of the subjects had a loss of the orbicularis 
oculi motor response to stimulation prior to the loss of 
motor response to stimulation at the adductor pollicis. The 
minimum time to loss of twitch response at the orbicularis 
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oculi was 5 5  seconds with a maximum of 1 5 2  seconds and a 
mean of 85.4 5 seconds. The variance was shown to be 779. 3 1  
seconds with a standard deviation o f  27.91 seconds. The 
minimum time to the loss of twitch response at the adductor 
pollicis was 149 seconds with a maximum of 43 5 seconds and a 
mean of 230. 25  seconds. The variance was f ound to be 
5, 786. 93 seconds and a standard deviation of  76.07 seconds. 
In all subjects, the loss of the twitch at the orbicularis 
oculi occurred f irst and laryngoscopy was performed. All 20 
of the subj ects had visible, open, immobile vocal cords 
through which an endotracheal tube was passed. One subject 
showed movement  during placement of the endotracheal tube. 
The time to loss of t he t w i tch response at the orbicularis 
oculi was subtracted f , om t he time to loss of the twitch 
response at the adduc t �r �c l l icis for each patient. This 
resulted in a minimum d 1 f ! � , ence of 73 seconds and a maximum 
dif f erence of  283 sec c � � s  � 1 t h a mean dif f erence of 144.80 
seconds. All of  the p a : 1 e r. t s  exhibiting longer times to 
loss of twitch respor. s e  ; �  t he arm and face were males and 
had an ASA classif ica t i on 0 1  II. 
Comparison of Cardiq�a � c u l a r  Response 
The arterial systolic and diastolic pressure of each 
subject was obtained using non-invasive blood pressure 
monitoring. A baseline blood pressure was obtained prior to 
induction of  neuromuscular blockade and anesthesia, as well 
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as, 5 minute s and 1 0  minute s  af te r induction of gene ral 
ane s the sia had occurred. The mean arte rial pre s sure (MAP ) 
was de rived by the addition of the sys tolic pre s sure and 
twice the dias tolic pre s sure and dividing the s um by 3 for 
each subJ ect. The baseline MAP ranged f rom 68 to 1 2 6  mmHg 
with a mean of 90.4. At 5 minute s, the MAP has a wide r 
range than the baseline MAP at 43. 7 to 1 4 5 . 7  mmHg , but the 
mean MAP at 5 minute s  was lowe r than the baseline at 85. 9 
mmHg. The mean MAP at 10 minute s  was lower than both the 
baseline and 5 minute mean MAP at 80. 1 mmHg. The MAP 
standard deviation at 5 minute s and 10 minute s  was greater  
than the MAP standard deviation at the baseline as  well. 
Three subJ ect s out of the 2 0  had declines of greate r than 
20% of their baseline MAP at the 5 minute measurement and 
six patients  had a greate r than 20% decline in the i r  MAP at 
the 10 minute measurement. One subject out of the 2 0  had an 
increase in MAP greate r than 20% of the baseline at the 5 
minute measurement. 
The heart rate measurements  we re obtained f rom a f ive 
lead e lectrocardiogram (EKG) monitor placed on each subJ ect 
and recorded prior to induction of neuromuscular and 
ane sthe tic induction and at 5 minute and 10 minute time 
pe riods. The mean heart rate measurements  show little 
variation be tween the three monitored time s. The lowe s t  
mean hear t rate was 7 3. 5 a t  baseline and the highe s t  was 
82. 7 at the 5 minute time period. 
Chapter Five 
Discussion 
Discussion of Twitch Response 
The statistical analysis of the data prov ided 
signif icant ev idence that a difference exists between the 
time to loss of twitch response at the orbicularis ocu l i  and 
the adductor pollicis muscles. Therefore , the null 
hypothesis was rejected. This statement was supported by 
the fact that 100 % of the study subjects lost the mean 
twitch response ( MTR) at the orbicularis oculi 1 4 4.8 seconds 
prior to the loss of the MTR at the adductor pol l icis. 
These results were in agreement with the work of Donati 
et al. (1990) who showed that the smaller muscles of the 
orbicularis and the larynx succumb to neuromuscular blockade 
before the larger muscles of the adductor pollicis. 
According to the work of Johnson et al. ( 1973), 90 % of the 
orb icularis ocul i muscle is composed of fast contracting, 
Type II muscle f ibers. The adductor pol l icis is composed 
primarily of slow contracting, Type I muscle f ibers. 
Differences in muscle f iber type may explain some of the 
dif ferences in  the time to the loss of twitch response at 
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these two monitored sites. C laassen and Werner (19 9 2) 
studied the muscle fiber composition of  the larynx. Their 
results demonstrated that the muscles responsible for the 
adduction of the vocal cords ( lateral cricoarytenoids, 
cricothyroid) are primarily composed of Type II  muscle 
fibers whereas the abductor (posterior cricoarytenoid) is 
primarily composed of Type I muscle fibers. I f  the muscle 
fiber type was responsible for the differences in the loss 
of MTR at the orbicularis and adductor pollicis, the same 
should hold true for the laryngeal muscles. The results 
obtained in the study helped to confirm this postulate by 
virtue of the vocal cords being open for each laryngoscopy 
attempted at the loss of twitch response at the orbicularis 
oculi. Donati et al. (1 991) studied the onset of 
neuromuscular blockade at the larynx , diaphragm and adductor 
pollicis. These researchers f ound thaL the paralysis of the 
laryngeal muscles and the diaphragm precede the adductor 
pollicis. The diaphragm, however, is predominantly composed 
of Type I muscle f ibers. This seemingly contradicted the 
postulate that time of onset of neuromuscular blockade was 
due to muscle fiber type. The explanation for this may be 
preferential blood flow to the diaphragm. T his pref erential 
blood flow allows a greater amount of the NTBA to reach the 
muscle fibers of the diaphragm before the equivalent amount 
reaches the adductor pollicis. This large concentration 
shortens Lhe time to 100 %  twitch depression ( Miller, 198 5). 
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I wasaki et al. (1 9 94) directly measured the response of 
muscle stimulation using EMG at the CT and PCA muscles 
during the onset of  neuromuscular blockade. The results 
obtained f ound that the PCA (predominantly Type I) muscle, 
is more resistant and takes longer to develop 100% 
neuromuscular blockade than does the CT muscle 
(predominantly Type II ) .  Theref ore, paralysis of the CT 
muscle allows unopposed abduction of the vocal cords by the 
PCA muscle. 
The results from this study also showed that the time 
to loss of MTR in males were longer than in females. The 
size of the sample population and the fact that only 20% of 
the sample population was female may have contributed to 
this result. A larger sample population may very well 
revealed that no dif ference exists based on sex. 
Discussion of Cardiovascular Results 
The facial and truncal erythema exhibited by one 
subJ ect and the decline of  > 20 %  of baseline MAP of three 
subj ects at the 5 minute interval and six subjects at the 10 
minute interval, are somewhat higher than previous studies 
have shown for a single dose of 0.1 mg / kg mivacurium, but 
lower than a single dose of  0.2 mg / kg mivacurium. Savarese 
et al. (1 989) revealed a decline of  > 20%  in baseline MAP in 
0 / 9  subjects studied given a bolus of 0. 1 mg / kg mivacurium 
and 4/9 subjects given the 0.2 mg /kg mivacurium bolus. 
Savarese et al . (1989) controlled for variables that could 
cause a decline of MAP such as the induction dose of 
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thiopental and the use of volatile anesthetics . Intubation 
was achieved without muscle relaxant and a consistent 
baseline of MAPs were obtained prior to giving the bolus of 
mivacurium. Decline in MAP due to mivacurium alone could be 
more accurately obtained with this method. The decline of 
the MAP due to the dose of mivacurium in the subjects of 
this study cannot be isolated f rom those who experienced a 
decline of MAP due to the induction dose of propofol or the 
use of volatile inhalation agents. 
Conclusions 
It can be concluded f rom this study that there is a 
shorter time to loss of twitch response at the orbicularis 
oculi than at the adductor pollicis using 0. 2 mg/ kg 
mivacurium chloride in equally divided doses given 30 
seconds apart. It can also be concluded that when the loss 
of twitch response at the orbicularis oculi occurs, the 
vocal cords are open when using 0. 2 mg/ kg mivacurium 
chloride in equally divided doses given 3 0  seconds apart. 
Finally, it is concluded that age, sex , weight, and ASA 
class have no effect on the onset of neuromuscular blockade 
in the sample population studied. 
Cl inica l Significa nce 
Monitoring t he onset of neuromuscul a r  b l ocka de a t  t he 
orbicul a ris ocul i muscl e gives t he p ract i t i oner a more 
a ccurat e  monitor of l a ry ngea l muscl e para l ysi s  t ha n  does 
monitoring t he a dduct or pol l i cis. Thi s correl a t i on of the 
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orbicul a ris ocul i a nd l a ryngea l muscl e para l ysi s  a l l ows for 
rap id p l acement of the endotrachea l tube fol l owing l a ry ngea l 
muscl e p a ra l ysis. This rap i d  p l acement of the endotra chea l 
t ub e  decrea ses t he risk for ga stric a sp i ra t ion a nd the onset 
of hypoxia . 
I mpl ications for Further St udies 
A larger samp l e  popul ation using t he same st udy 
t echniques ma y exp l a in the sl i ght di fferences found bet ween 
ma l e  a nd fema l e  sub j ect s a nd t he t ime requi red to  obta i n  
10 0 %  neuromuscul a r  b l ocka de. A l a rger sa mp l e  popul a t i on ma y 
a l so p rovide more supportive data correl a t i ng cha nges i n  MAP 
a nd t he onset of neuromuscul a r  b l ocka de. A study monitori ng 
t he onset a nd ca rdiova scul a r  effect s of 0 . 2 mg/ kg mi va curi um 
used in spl it dosa ges woul d be benefi ci a l  to  pract i t i oners . 
The resul t ing cha nges i n  hi st a mi ne rel ease a nd MAP coul d be 
mea sured a ft er maint ena nce of a stabl e  b a sel ine of MAP ha d 
b een obt ained fol l owing t he induct i on of anest hesi a .  Thi s 
would a ll ow for a more a ccurate representa t ion of t he effect 
of di vi ding t he dose of miva curi um. 
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